Gastrointestinal Stromal Tumor (GIST)

Showing NaN - NaN of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Gastrointestinal Stromal Tumor (GIST) Trial in New York (MEK162, Pexidartinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 29, 2021

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
  • Melanoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Gastrointestinal Stromal Tumor (GIST) Trial in United States (imatinib mesylate)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • imatinib mesylate
  • La Jolla, California
  • +20 more
Mar 9, 2018